SSDV Annual Congress 2024
< back to event website
Converia – Conference Management Software

Detailed contribution information

Back to list

Contribution title Lebrikizumab Monotherapy Maintained Improvement of Itch and Sleep-Loss Due to Itch After Two Years in Patients with Moderate-to-Severe Atopic Dermatitis
Authors
  1. Gil Yosipovitch Itch Center, Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Hospital
  2. Peter A. Lio Northwestern University Feinberg School of Medicine; Medical Dermatology Associates of Chicago
  3. David Rosmarin Indiana University School of Medicine
  4. Marta Casillas Eli Lilly and Company
  5. Evangeline Pierce Eli Lilly and Company
  6. Laia Bardolet Almirall S.A.
  7. Franz J. Legat Department of Dermatology, Medical University of Graz
  8. Jose-Manuel Carrascosa Dermatology Department, Hospital Universitari Germans Trias i Pujol, UAB, IGTP
  9. Sonja Stander Department of Dermatology and Center for Chronic Pruritus (KCP), University Hospital Münster, Münster Presenter
Form of presentation Poster
Topic
  • 1.1 Inflammatory and immune-mediated dermatoses